7 October 2020
Cambridge Cognition has won a new contract providing cognitive tests and electronic clinical outcome assessments for an Alzheimer’s trial. The total Contract is worth approximately £750,000 over two years, with a considerable proportion of the revenue for the Company expected to be received in 2021.
1 September 2020
Cambridge Cognition is pleased to announce that it has won a £2m contract as the cognitive assessment partner for three late phase clinical trials for a pharmaceutical company's lead drug candidate for patients with schizophrenia. It is one of the largest single contracts secured by the Company and the revenue from the contract should be booked over the next four years with the majority recognised in 2021.
15 July 2020
New virtual study to measure stress recovery in frontline health workers caring for COVID-19 patients
Cambridge Cognition is pleased to announce a collaboration with 4YouandMe and The Center for International Emergency Medical Services to investigate the utility of wearables and mobile phones for measuring stress recovery in frontline health workers caring for COVID-19 positive patients.
30 June 2020
Further contract wins in the first half of 2020 takes the Company's order intake to £4.9m for the year to date.
27 May 2020
The results of the 2020 CANTAB Research Grant are in! Once again we were overwhelmed by the quality of applications we received – which made it a tough job for our judging panel to narrow the research proposals down.
27 May 2020
Cambridge Cognition is pleased to announce that the Company has recently won several new contracts to support pharmaceutical clients in delivering virtual clinical trials, including two contracts collectively worth over £1 million.